Moonlight Therapeutics is a biotechnology startup, founded in 2017. The company is dedicated to developing safe, effective, and patient-friendly therapies for individuals afflicted with food allergies. Its initial focus is on creating a treatment specifically designed for children and adults with peanut allergies. Moonlight Therapeutics operates within the industries of biotechnology, healthcare, and life sciences, and is headquartered in the United States. As of now, there is no publicly available information regarding their last investment or the involved investors. With its commitment to addressing a critical health concern and a focus on patient-friendly solutions, Moonlight Therapeutics presents an intriguing prospect for potential venture capital interest.
There is no investment information
No recent news or press coverage available for Moonlight Therapeutics.